Explore our website
Welcome to the Knowledgebase, an online resource, where you can search for information about allergy.
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
AllergyWise is the easiest way to learn about anaphylaxis, the risks of severe allergies and how to safely manage them, conveniently from your home or workplace, wherever and whenever it suits you.
The Anaphylaxis Campaign are the only UK wide charity operating solely for people at risk from severe allergic reactions. Click here to find out who we are, what we do and who supports us.
25th March 2017
Update 25th March 2017 MEDA the company who distribute EpiPens in the UK have now released a statement and shared this with the Anaphylaxis Campaign. You can read this below. We will continue to keep you updated on this issue. If you have any queries please contact our helpline – 01252 542029, firstname.lastname@example.org or contact […]
24th March 2017
UPDATE 14.45pm 24/3/2017 After further consultation with the EpiPen distributors this morning, we have been advised that the batch affected by the recall is Lot 5FA665, with expiry dates of March, April, or May 2017. If you have or if your child has an EpiPen 300 mcg with a Lot/Batch code beginning 5FA665 and with […]
23rd March 2017
The European Parliament Interest Group on Allergy and Asthma, coordinated by European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) and EAACI, is initiating a Political Call to Action addressed to EU and National policy makers, and civil society stakeholders to act on Allergy and Asthma in Europe. The EFA is an alliance of 41 allergy, […]
22nd March 2017
Anaphylaxis Campaign are excited to announce that our dedicated anaphylaxis forum will open on Friday 31 March 2017. The forum will be run in collaboration with talkhealth, a leading trusted online health community, who will be hosting and moderating on our behalf. We hope the forum will give you the opportunity to ask for and […]